Avalo Therapeutics, Inc.
NASDAQ:AVTXBiotechnology
Healthcare
$6.70 -2.18%
-$0.34 today
- Market cap
- $387.41M
- Beta
- 0.82
- P/E (TTM)
- -3.6
- EPS (TTM)
- -$4.21
52W Low $4.50High $24.27
Volume 1.58M
Average 1.61M
Price history
Avalo Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-61.91%
Period high
$22.87
Period low
$6.63
Latest
$6.70
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G | Nov 13, 2026 | Nov 13, 2026 | |
| SC 13G | Nov 10, 2026 | Nov 10, 2026 | |
| SC 13G/A | Nov 6, 2026 | Nov 6, 2026 | |
| SC 13G/A | Nov 5, 2026 | Nov 5, 2026 | |
| 10-Q | Nov 5, 2026 | Nov 5, 2026 | |
| 424B5 | Nov 5, 2026 | Nov 5, 2026 | |
| 8-K | Nov 5, 2026 | Nov 5, 2026 | |
| 8-K | Nov 5, 2026 | Nov 5, 2026 | |
| S-3ASR | Nov 5, 2026 | Nov 5, 2026 | |
| SC 13G | Oct 29, 2026 | Oct 29, 2026 | |
| 4 | Oct 2, 2026 | Oct 2, 2026 | |
| 4 | Oct 2, 2026 | Oct 2, 2026 | |
| 4 | Oct 2, 2026 | Oct 2, 2026 | |
| 4 | Sep 18, 2026 | Sep 18, 2026 | |
| 4 | Sep 11, 2026 | Sep 11, 2026 |
Competitors
Who does Avalo Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about AVTX's filings, answered from its disclosures.
What is the latest AVTX filing?
The latest filing shown is SC 13G dated Nov 13, 2026.
How many recent filings does AVTX have?
Intrinsic Alpha currently shows 20 recent filings for AVTX.
Continue the stock analysis
Jump to another research area for this company.